Jeisys Medical Inc
KOSDAQ:287410
Jeisys Medical Inc
Long-Term Debt
Jeisys Medical Inc
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Long-Term Debt
₩27.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
116%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Long-Term Debt
₩73.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Long-Term Debt
₩83.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
317%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Long-Term Debt
₩1.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Long-Term Debt
₩339m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Long-Term Debt
₩1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jeisys Medical Inc
Glance View
Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.
See Also
What is Jeisys Medical Inc's Long-Term Debt?
Long-Term Debt
27.3B
KRW
Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Long-Term Debt amounts to 27.3B KRW.
What is Jeisys Medical Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
116%
Over the last year, the Long-Term Debt growth was 144%. The average annual Long-Term Debt growth rates for Jeisys Medical Inc have been 48% over the past three years , 116% over the past five years .
